Retatrutide
| # of Vials | Price (AUD) |
|---|---|
| 1 | $89.95 |
| 2 | $169.95 (5% Discount) |
| 3 | $249.95 (10% Discount) |
| 4 | $319.95 (15% Discount) |
| 5 | $349.95 (20% Discount) |
⚠️Shipping Update: Shipping may take longer than usual due to high order volume. We appreciate your understanding and patience.
What It Is
Retatrutide is a Triple-Agonist peptide compound of significant interest in metabolic research.It functions by targeting three distinct hormonal pathways simultaneously. This results in a more comprehensive approach to metabolic regulation and weight management than previously possible with single or dual-action peptides.
What It Does
The "Triple Agonism" effect is achieved by stimulating three key receptors:
- • GLP-1 (Glucagon-like Peptide-1): Responsible for signaling satiety (fullness) to the brain and slowing gastric emptying, which significantly reduces "food noise."
- • GIP (Glucose-dependent Insulinotropic Polypeptide): Works to improve insulin sensitivity and helps the body efficiently break down fats and stabilize blood sugar.
- • Glucagon: Increases resting energy expenditure (thermogenesis), encouraging the body to burn more calories even while at rest.
What You Will Receive
Your AMANA Therapeutics Research Kit is a complete, pharmaceutical-grade solution:
- ✅ 10mg of 99.8% Purity Retatrutide (Research Grade)
- ✅ Convenient, Pre-filled Injection Pen (No manual mixing required)
- ✅ 5x Sterile Needle Caps
- ✅ Unlimited 1-on-1 Customer Support Access
Administration Reference (Laboratory Use Only)
For researchers conducting studies with this compound:
- Dosing: Research protocols typically employ doses of 2-10mg weekly. Dosing intervals and amounts vary by research protocol design. Researchers should consult published literature and institutional guidelines.
- Administration: Subcutaneous administration has been employed in research settings. Proper sterile technique is essential.
- Storage: Maintain at 2-8°C to preserve compound integrity.
This information is provided for research professionals only. Users should be familiar with their institution's IRB approval and applicable regulations.